Merck Scientist Testifies Vioxx Caused More Heart Attacks Than ...
LOS ANGELES - People who took part in a clinical trial of the pain reliever Vioxx had heart attacks at a rate four times higher than those taking an older painkiller, a health data analyst for Merck and Co. testified today.
Deborah Shapiro, director of clinical biostatistics for Merck and Co. -- which marketed Vioxx from 1999 to 2004 -- said in a videotaped deposition shown to a jury that half of the 8,000 patients in the study took Vioxx and the other half naproxen, known by the brand name Aleve
· Read The Full Vioxx Article From North County Times -->
·
Read All Vioxx (Rofecoxib) News Stories -->